Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell of lymphatic vessel | 16 studies | 34% ± 17% | |
| oligodendrocyte precursor cell | 14 studies | 42% ± 16% | |
| astrocyte | 13 studies | 48% ± 21% | |
| fibroblast | 12 studies | 29% ± 18% | |
| glutamatergic neuron | 12 studies | 63% ± 25% | |
| GABAergic neuron | 11 studies | 47% ± 23% | |
| endothelial cell | 11 studies | 28% ± 15% | |
| mesothelial cell | 9 studies | 43% ± 22% | |
| smooth muscle cell | 6 studies | 44% ± 21% | |
| connective tissue cell | 6 studies | 32% ± 8% | |
| interneuron | 6 studies | 53% ± 25% | |
| neuron | 5 studies | 33% ± 11% | |
| epithelial cell | 4 studies | 30% ± 16% | |
| progenitor cell | 3 studies | 40% ± 8% | |
| vein endothelial cell | 3 studies | 21% ± 4% | |
| GABAergic interneuron | 3 studies | 50% ± 10% | |
| myofibroblast cell | 3 studies | 24% ± 6% | |
| retinal pigment epithelial cell | 3 studies | 56% ± 28% | |
| GABAergic amacrine cell | 3 studies | 33% ± 10% | |
| Mueller cell | 3 studies | 31% ± 5% | |
| amacrine cell | 3 studies | 33% ± 15% | |
| adventitial cell | 3 studies | 25% ± 9% | |
| chondrocyte | 3 studies | 35% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 14 studies | 45% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 6984.95 | 328 / 328 | 78% | 4.03 | 139 / 178 |
| brain | 78% | 2257.64 | 2062 / 2642 | 73% | 2.15 | 512 / 705 |
| thymus | 98% | 3261.44 | 641 / 653 | 51% | 1.38 | 308 / 605 |
| prostate | 96% | 2402.75 | 234 / 245 | 48% | 0.95 | 240 / 502 |
| breast | 91% | 1857.55 | 417 / 459 | 50% | 1.34 | 562 / 1118 |
| ovary | 100% | 8975.83 | 180 / 180 | 36% | 0.90 | 153 / 430 |
| skin | 98% | 3409.79 | 1780 / 1809 | 35% | 1.46 | 164 / 472 |
| uterus | 95% | 1813.36 | 162 / 170 | 37% | 1.47 | 172 / 459 |
| bladder | 100% | 2167.86 | 21 / 21 | 19% | 0.63 | 97 / 504 |
| adrenal gland | 90% | 1454.62 | 233 / 258 | 25% | 0.86 | 58 / 230 |
| lung | 67% | 904.54 | 388 / 578 | 48% | 1.50 | 556 / 1155 |
| esophagus | 64% | 930.64 | 920 / 1445 | 50% | 2.27 | 91 / 183 |
| spleen | 98% | 2027.29 | 237 / 241 | 0% | 0 | 0 / 0 |
| adipose | 96% | 3792.68 | 1152 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 70% | 1110.16 | 677 / 966 | 15% | 0.53 | 81 / 527 |
| blood vessel | 85% | 1677.86 | 1129 / 1335 | 0% | 0 | 0 / 0 |
| stomach | 42% | 569.51 | 150 / 359 | 33% | 1.04 | 94 / 286 |
| muscle | 69% | 1302.38 | 554 / 803 | 0% | 0 | 0 / 0 |
| kidney | 51% | 610.22 | 45 / 89 | 10% | 0.26 | 86 / 901 |
| tonsil | 0% | 0 | 0 / 0 | 51% | 1.82 | 23 / 45 |
| heart | 47% | 933.27 | 408 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 38% | 0.89 | 30 / 80 |
| liver | 8% | 65.07 | 18 / 226 | 14% | 0.86 | 55 / 406 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 0.23 | 5 / 29 |
| peripheral blood | 0% | 0.63 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_2001222 | Biological process | regulation of neuron migration |
| GO_0061343 | Biological process | cell adhesion involved in heart morphogenesis |
| GO_0008150 | Biological process | biological_process |
| GO_0050919 | Biological process | negative chemotaxis |
| GO_0071711 | Biological process | basement membrane organization |
| GO_0051965 | Biological process | positive regulation of synapse assembly |
| GO_0003007 | Biological process | heart morphogenesis |
| GO_0007411 | Biological process | axon guidance |
| GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0043005 | Cellular component | neuron projection |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0005911 | Cellular component | cell-cell junction |
| GO_0045202 | Cellular component | synapse |
| GO_0005104 | Molecular function | fibroblast growth factor receptor binding |
| GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
| GO_0045499 | Molecular function | chemorepellent activity |
| Gene name | FLRT2 |
| Protein name | Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2) Fibronectin leucine rich transmembrane protein 2 |
| Synonyms | UNQ232/PRO265 KIAA0405 |
| Description | FUNCTION: Functions in cell-cell adhesion, cell migration and axon guidance. Mediates cell-cell adhesion via its interactions with ADGRL3 and probably also other latrophilins that are expressed at the surface of adjacent cells. May play a role in the migration of cortical neurons during brain development via its interaction with UNC5D. Mediates axon growth cone collapse and plays a repulsive role in neuron guidance via its interaction with UNC5D, and possibly also other UNC-5 family members. Plays a role in fibroblast growth factor-mediated signaling cascades. Required for normal organization of the cardiac basement membrane during embryogenesis, and for normal embryonic epicardium and heart morphogenesis. . |
| Accessions | ENST00000682132.1 ENST00000330753.6 ENST00000554746.1 ENST00000683129.1 ENST00000684303.1 A0A804HKH2 O43155 |